Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20121
20143
20171
20181
20202
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Recruiting2
Active, not recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Isofol Medical AB3
Lund University Hospital2
Pfizer2
Anthos Therapeutics, Inc.1
GlaxoSmithKline1
Karolinska Institutet1
Linkoeping University1
Region Skane1
Repos Pharma1
Sahlgrenska University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms14
Colorectal Neoplasms6
Intestinal Neoplasms6
Digestive System Neoplasms5
Gastrointestinal Diseases5
Digestive System Diseases4
Intestinal Diseases3
Neoplasms3
Rectal Neoplasms3
Colonic Neoplasms2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.